Triazolopyridazines as tyrosine kinase modulators

Details for Australian Patent Application No. 2006331912 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Johnson, Dana L.; Connors, Richard W.; Sechler, Jan L.; Khalil, Ehab; Cummings, Maxwell D.; Maroney, Anna C.; Lu, Tianbao; Galemmo, Robert A.; Markotan, Thomas P.; Travins, Jeremy M.; Alexander, Richard; Hufnagel, Heather Rae; Leonard, Kristi A.; Tuman, Robert W.

Agent Shelston IP

Pub. Number AU-B-2006331912

PCT Pub. Number WO2007/075567

Priority 60/752,634 21.12.05 US

Filing date 18 December 2006

Wipo publication date 5 July 2007

Acceptance publication date 30 August 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 - ortho- or peri-condensed with heterocyclic ring systems

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075567 Priority application(s): WO2007/075567

30 August 2012 Application Accepted

  Published as AU-B-2006331912

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331917-Orally active purine-based inhibitors of heat shock protein 90

2006331910-Diagnostic system for the detection and diagnosis of skin cancer